Urticarial vasculitis coexisting with primary myelofibrosis – a case report
Przegląd Dermatologiczny, 2017 Introduction . Urticarial vasculitis is a subtype of cutaneous leukocytoclastic vasculitis. The disease often accompanies systemic disorders, including hematologic malignancies, connective tissue diseases, and infectious diseases, or may be drug-induced.
Radomir Reszke, Adam Reich
doaj +1 more source
Defective erythropoiesis in primary myelofibrosis associated with a chromosome 11 abnormality [PDF]
, 1991 WN Patton +3 more
openalex +1 more source
Blood, 2019 TO THE EDITOR: The discovery of prognostically informative mutations in patients with primary myelofibrosis (PMF)[1][1] prompted the development of mutation-enhanced risk scores.[2][2][⇓][3][⇓][4][⇓][5]-[6][6] Among these mutations, those in ASXL1 are ...
G. Rotunno +15 more
semanticscholar +1 more source
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis [PDF]
, 2007 Giovanni Barosi +16 more
openalex +1 more source
Thalidomide and lenalidomide in primary myelofibrosis.
The Netherlands journal of medicine, 2010 Primary myelofibrosis is a clonal haematopoietic stem cell disease, characterised by marrow stromal fibrosis, extramedullary haematopoiesis, splenomegaly, hepatomegaly and progressive cytopenia. Therapeutic options once cytopenia has developed are limited to supportive care, such as erythrocyte transfusions and growth factors.
Holle, N. +4 more
openaire +3 more sources
Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1low mouse model of the disease [PDF]
, 2008 Anna Ritá Migliaccio +10 more
openalex +1 more source
A New Prognostic Scoring System for Primary Myelofibrosis Based on a Study of the International Working Group for Myelofibrosis Research and Treatment [PDF]
, 2008 Francisco Cervantes +11 more
openalex +1 more source
Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome
Clinics, 2013 OBJECTIVES: To evaluate whether risk scores used to classify patients with primary myelofibrosis and JAK-2 V617F mutation status can predict clinical outcome.
Bruno Deltreggia Benites +8 more
doaj
Bone Morphogenetic Proteins Are Overexpressed in the Bone Marrow of Primary Myelofibrosis and Are Apparently Induced by Fibrogenic Cytokines [PDF]
, 2008 Oliver Bock +6 more
openalex +1 more source
Therapeutic Advances in HematologyBackground: Secondary myelofibrosis (SMF) is characterized by the excessive deposition of fibrous tissue on top of the primary disease, often causing clinical manifestations to be overshadowed by the primary disease.
Han Xu +10 more
doaj +1 more source